When a patient is battling cancer, understanding all available treatment options is important.
Southside Hospital’s Benjamin Schwartz, MD, a gynecologic oncologist and director of the OB/GYN service line in Northwell Health’s Eastern Region, and Gary Deutsch, MD, surgical oncologist at Imbert Cancer Center, have begun offering a new high-dose, localized cancer treatment called hyperthermic intraperitoneal chemotherapy (HIPEC).
Dr. Schwartz answered the following questions about the method.
What does HIPEC involve?
This treatment takes highly concentrated chemotherapy and places it directly on the cancerous cells during surgery. When performing this procedure, surgeons inject the concentrated chemotherapy into the affected area for 90 minutes.
Why is HIPEC effective in destroying cancer cells?
For one thing, the chemotherapy is being applied directly to the cancer cells, which is more effective than going through the bloodstream. But the heat involved in the delivery of the chemotherapy also helps weaken cancer cells.
Who would best be suited for this procedure?
There’s a broad range of applications. HIPEC can be performed on patients who have abdominal cancers such as appendix cancer, colon cancer, ovarian cancer or uterine cancer. Consult with your oncologist about this option after other avenues have been pursued.